SFTPD and COVID-19: Herein, we have shown that COVID-19 patients exhibit a decreased concentration of pulmonary SP-D (median = 68.9 ng/mL) compared with the levels reported in the literature for healthy subjects, which range from 900–1300 ng/mL [32,33,34].